InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Joshua T Brumm, a See Remarks, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 21 open-market SEC Form 4 transactions: 0 purchases worth $0 and 21 sales worth $20.3M, reported from Sep 20, 21 to Jun 22, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 26 | CBIOCRESCENT BIOPHARMA, INC. | SELL | 42.3K | $17.99 | $761K |
| Mar 11, 24 | DYNDyne Therapeutics, Inc. | SELL | 40.1K | $26.12 | $1.0M |
| Mar 8, 24 | DYNDyne Therapeutics, Inc. | SELL | 202.2K | $27.38 | $5.1M |
| Mar 7, 24 | DYNDyne Therapeutics, Inc. | SELL | 9.1K | $25.85 | $235K |
| Mar 1, 24 | DYNDyne Therapeutics, Inc. | SELL | 74.1K | $29.70 | $2.2M |
| Feb 29, 24 | DYNDyne Therapeutics, Inc. | SELL | 5.5K | $27.50 | $152K |
| Jan 4, 24 | DYNDyne Therapeutics, Inc. | SELL | 180.2K | $19.05 | $3.3M |
| Jan 3, 24 | DYNDyne Therapeutics, Inc. | SELL | 19.8K | $20.50 | $376K |
| Dec 11, 23 | DYNDyne Therapeutics, Inc. | SELL | 7.6K | $10.72 | $81K |
| Sep 18, 23 | DYNDyne Therapeutics, Inc. | SELL | 12.0K | $9.41 | $113K |
| Sep 12, 23 | DYNDyne Therapeutics, Inc. | SELL | 7.7K | $10.41 | $80K |
| Jun 12, 23 | DYNDyne Therapeutics, Inc. | SELL | 187.7K | $12.61 | $2.4M |
| Jun 9, 23 | DYNDyne Therapeutics, Inc. | SELL | 76.6K | $13.34 | $1.0M |
| Jun 8, 23 | DYNDyne Therapeutics, Inc. | SELL | 46.8K | $13.47 | $616K |
| Mar 14, 23 | DYNDyne Therapeutics, Inc. | SELL | 7.3K | $13.33 | $98K |
| Dec 12, 22 | DYNDyne Therapeutics, Inc. | SELL | 3.3K | $10.87 | $36K |
| Oct 10, 22 | DYNDyne Therapeutics, Inc. | SELL | 195.8K | $12.46 | $2.4M |
| Oct 7, 22 | DYNDyne Therapeutics, Inc. | SELL | 14.2K | $13.37 | $190K |
| Mar 11, 22 | DYNDyne Therapeutics, Inc. | SELL | 3.4K | $8.73 | $30K |
| Sep 21, 21 | DYNDyne Therapeutics, Inc. | SELL | 4.6K | $16.11 | $74K |
| Sep 20, 21 | DYNDyne Therapeutics, Inc. | SELL | 3.4K | $15.61 | $53K |